Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 8—August 2006
Research

VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1

Thierry Naas*2Comments to Author , Bruno Coignard†2, Anne Carbonne‡, Karine Blanckaert‡, Odile Bajolet§, Claude Bernet¶, Xavier Verdeil#, Pascal Astagneau‡, Jean-Claude Desenclos†, Patrice Nordmann*, on behalf ofthe French Nosocomial Infection Early Warning, Investigation and Surveillance Network
Author affiliations: *Hôpital de Bicêtre, Le Kremlin-Bicêtre, France; †Institut de Veille Sanitaire, Saint-Maurice, France; ‡Centre de Coordination de Lutte contre les Infections Nosocomiales Paris Nord, Paris, France; §Réseau Bactéries Multi-Résistantes Champagne-Ardennes, Centre Hospitalier et Universitaire, Reims, France; ¶Centre de Coordination de Lutte contre les Infections Nosocomiales Sud-Est, Lyon, France; #Centre de Coordination de Lutte Contre les Infections Nosocomiales Sud-Ouest et Centre Hospitalier et Universitaire, Toulouse, France

Main Article

Figure 1

Figure 1. Number of VEB-1–producing Acinetobacter baumannii cases, by month of report, France, July 2003–May 2004 (N = 255).

Main Article

1This study was presented in part at the 2004 Annual Conference on Antimicrobial Resistance: Science • Prevention • Control, June 28–30, 2004, Bethesda, Maryland, USA.

2These authors contributed equally to this work.

Page created: December 09, 2011
Page updated: December 09, 2011
Page reviewed: December 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external